An evidence based review of acute and long-term effects of cannabis use on executive cognitive functionsA Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid AddictionAdapting Screening, Brief Intervention, and Referral to Treatment for Alcohol and Drugs to Culturally Diverse Clinical PopulationsElectronic cigarettes: a review of safety and clinical issuesAssociations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis.Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.Institutional Substance Use Disorder Intervention Improves General Internist Preparedness, Attitudes, and Clinical Practice.Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film.Patient relapse in the context of drug abuse treatment.A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependenceCombat posttraumatic stress disorder, substance use disorders, and traumatic brain injurySubstituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine.Misuse of Novel Synthetic Opioids: A Deadly New Trend.Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids.Science and electronic cigarettes: current data, future needs.Alcohol-Dependent Subjects Show Different Personality Traits Compared With Subjects With Multiple Substance Dependence: Preliminary Data.Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.Acamprosate: safety and tolerability in the treatment of alcohol dependence.Acculturation stress, anxiety disorders, and alcohol dependence in a select population of young adult Mexican AmericansClinical Case Discussion: Pathological Gambling and Nicotine Dependence.Anxiety sensitivity and negative urgency: a pathway to negative reinforcement-related smoking expectancies.Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies.The Treatment of Obesity and Its Co-occurrence with Substance Use DisordersConventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: a needs assessment study.Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid DependenceSafety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study.Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceLow vitamin d status of patients in methadone maintenance treatmentClinical case discussion: binge eating disorder, obesity and tobacco smoking.The relation between smoking status and medical conditions among incarcerated adults.Exploration of food addiction in pediatric patients: A preliminary investigationSuccessful integration of hepatitis C evaluation and treatment services with methadone maintenance.Prescription opioid use among patients seeking treatment for opioid dependence.Nicotine addiction in light smoking African American mothers.Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study.Client factors associated with length of stay in methadone treatment among heroin users who inject drugs: quantitative analysis of state-level substance abuse treatment utilization data.Quetiapine versus trazodone in reducing rehospitalization for alcohol dependence: a large data-base study.
P1433
Q24627250-CBA33F01-46D0-46D8-BA74-8A66BA476901Q28069995-A4494371-AF27-41E7-A32F-9BA2050EA00DQ28082595-C38E1399-F828-44A3-BE56-0D78E8D37E43Q28245172-6C90B41C-D8EC-4F33-BCBB-44621039FEDAQ30006158-D432B1ED-A4A8-4513-96CA-BBBB50B13887Q30006159-ABA42835-AF27-45CA-85D4-38D5E504E7ACQ30148775-FC919E21-9CB8-4B1C-B0F6-B8597328C906Q30277261-7FCBBB81-EE81-46CC-83CF-1FEC81179DACQ30406015-AFB9BCD6-14F4-4506-9EA0-18CF5637E74EQ30412161-53383F15-13A3-4566-B461-E8C90BE7FBA3Q30433266-5D01F33D-401A-4ED5-A2D4-DA22003D89BEQ30456717-AE78597C-FCCC-45CC-B30A-1A570AD308BAQ30456718-8DF63A8E-FDD2-4F05-804A-F4CEAD0599C0Q30491920-059D2372-987A-469E-94DD-DA9F7D611768Q30816828-D0C6F185-F090-4D31-AC76-94C5B1A988D1Q30840542-FB7ECA80-9649-410D-9C07-5C1B0C1DFF80Q30973304-27978BA7-7E85-41A6-8F52-AE9F305CD16DQ31155610-8E5815CA-6040-4E87-A327-6E9C63806845Q33166593-F46319D7-D54F-4D76-B101-0685442E6DF5Q33449522-588C3A2D-80E6-4E1C-9A93-BD198FCCD06CQ33451246-DD5C7CF1-D386-492E-8091-FD8EEDB110F6Q33584609-952CCE73-3633-429A-A002-29CA4CB1E1D6Q33588856-4D0569D9-C12A-425E-95D7-2EFC0925811DQ33692533-55FB253D-E5E7-49D2-9CB1-9C483E210AF8Q33704262-488D6EE1-4AE1-4026-BC8B-9A05260838F0Q33713548-B1CBC22B-1650-46D4-8724-8ABE9DE2A0D5Q33757801-FBC3A269-DB9B-440E-B88D-4089131FD910Q33760413-019555E2-8908-4744-890C-1351E5B16295Q33760418-CBB9545D-0367-42EF-8063-E929DDA3F6C3Q33760424-99C32A41-AAD7-492D-BCEC-897DA0E7B333Q33763986-83375C31-460E-454E-A43C-0BDEFE00D0D1Q33814959-B9E552E4-4633-4F37-BA2B-69D0B3DF50BCQ33829633-A3237987-4237-41F2-B798-DE4C7E570769Q33847614-EBC432AA-222E-42E5-9CEF-3ECD49E6C7C6Q33858467-3C8019EF-FCAC-4CA3-8728-E9B9420BD924Q33900277-D1A17FB7-0350-42A6-B6BD-CC3B186BF2B6Q33929899-154DFF2F-B976-498A-A93C-2EBD0B1395A1Q33930962-DABE10B5-8B96-41D2-9DE0-D2DFBB12965AQ33964942-F16BF426-EBF8-4FF5-A2E6-D2E28297EB76Q33964947-2BC6A206-BE11-4136-BDC6-30BCB804F6A9
P1433
description
Medical journal
@en-gb
Medizinische Fachzeitschrift
@de
Revue médicale
@fr
medical journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Lippincott Williams & Wilkins
@nl
медицинский журнал
@ru
name
Journal of Addiction Medicine
@ast
Journal of Addiction Medicine
@de
Journal of Addiction Medicine
@en
Journal of Addiction Medicine
@en-ca
Journal of Addiction Medicine
@en-gb
Journal of Addiction Medicine
@es
Journal of Addiction Medicine
@fr
Journal of Addiction Medicine
@it
Journal of Addiction Medicine
@nl
type
label
Journal of Addiction Medicine
@ast
Journal of Addiction Medicine
@de
Journal of Addiction Medicine
@en
Journal of Addiction Medicine
@en-ca
Journal of Addiction Medicine
@en-gb
Journal of Addiction Medicine
@es
Journal of Addiction Medicine
@fr
Journal of Addiction Medicine
@it
Journal of Addiction Medicine
@nl
altLabel
J. Addict. Med.
@de
J. Addict. Med.
@en
J. Addict. Med.
@en-gb
J. Addict. Med.
@fr
prefLabel
Journal of Addiction Medicine
@ast
Journal of Addiction Medicine
@de
Journal of Addiction Medicine
@en
Journal of Addiction Medicine
@en-ca
Journal of Addiction Medicine
@en-gb
Journal of Addiction Medicine
@es
Journal of Addiction Medicine
@fr
Journal of Addiction Medicine
@it
Journal of Addiction Medicine
@nl
P243
P3181
P1055
P1058
P1156
19200157106
P1159
P1160
J. Addict. Med.
P1277
P1476
Journal of Addiction Medicine
@en
P236
P243
P3181
P407
P571
2007-01-01T00:00:00Z